Atorvastatin

Active ingredient description

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
C10AA05
Atorvastatin
C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA05

Medicines

Atorvastatin is the active ingredient of these drugs:

Drug
Countries
ABARAN

Lithuania

AMICOR

Cyprus

ARKAS

Italy

ASTATOR

Lithuania

AT-LOR

Brazil

ATACOR

Hong Kong

ATAVOR

Singapore

ATEROMA

Brazil

ATOCOR

Singapore

ATOLIPIDRIN

Austria

ATORBIR

Finland

ATORGAMMA

Lithuania

ATORIS

Germany Hong Kong Italy Lithuania Poland

ATORKEY

Hong Kong

ATORLESS

Brazil

ATORLIP

Hong Kong

ATORNIDDA

Austria

ATORSAN

Singapore

ATORSTAN

Cyprus

ATORVACHOL

Australia

ATORVADIVID

Austria

ATORVAGEN

Poland

ATORVALAN

Austria

ATORVASTEROL

Brazil Poland

ATORVEX

Tunisia

ATORVILBITIN

Austria

ATORVON

Singapore

ATORVOX

Poland

ATOSTAT

Poland

ATOTY

Hong Kong

ATRACTIN

Poland

ATROVAST

Tunisia

ATROX

Poland

ATSWIFT

Singapore

BEATORVA

Singapore

BIOTOR

Hong Kong

CALIPRA

Poland

CALLATOR

Austria

CARATO

Hong Kong

CARDYL

Spain

CHLOVAS

Hong Kong

CHOLDOWN

Tunisia

CITALOR

Brazil

CORASTORVA

Brazil

CORATOR

Poland

DELIPOST

Cyprus

DIVATOR

Hong Kong

ETURION

Singapore

INATORVAS

Singapore

JEMATOR

Hong Kong

KOLESTER

Italy

KOLEVAS

Brazil

LAMBRINEX

Cyprus Poland

LAPTOR

Tunisia

LARUS

Poland

LESSTROL

Hong Kong

LIPICURE

Hong Kong

LIPIDUCE

Hong Kong

LIPIGET

Hong Kong

LIPIGRAN

Brazil

LIPIKHAN

Hong Kong

LIPISTAD

Finland Hong Kong

LIPISTAT

Brazil

LIPITOR

Australia Brazil Canada Cyprus Finland

LIPIVAS

Hong Kong

LIPIWON

Hong Kong

LIPOMID

Hong Kong

LIPTHAL

Brazil

LOPAMOL

Lithuania

LORSTAT

Australia New Zealand

LUMIRARTE

Brazil

MELEMIB

Italy

MODLIP

Lithuania

OLVASTIM

Poland

OMEGASTATIN

Italy

ORBEOS

Finland

ORVAKLINE

Hong Kong

PREVENCOR

Spain

SOPAVI

Italy

SORTIS

Austria Germany Lithuania Poland

STATINOR

Tunisia

STORVAS

Poland

SYNPITOR

Hong Kong

TAHOR

France Tunisia

TAVASTOR

Tunisia

TAXAT

Italy

THERVAN

Spain

TORVACARD

Cyprus Lithuania Poland

TORVACOL

Italy

TORVALIPIN

Poland Singapore

TORVARIN

Lithuania

TORVAST

Italy

TORVASTAT

Australia

TORVATEC

Hong Kong Singapore

TORVILIP

Brazil

TOTALIP

Italy

TOVANIRA

Italy

TROVAS

Australia

TULIP

Poland Singapore

VASPITOR

Hong Kong

VAST

Brazil

XARATOR

Hong Kong

XTOR

Hong Kong

ZARATOR

New Zealand Spain

Atorvastatin is also found within below combination drugs:

AMLATOR , AMLOSATIN , ANCILLEG , ASTUCOR , ATORDAPIN , ATORIMIB , ATORVALAN COMP , ATOZET , CADIVAST , CADUET , CODUWON , EUVASCOR , EXTROTAN , EZEATO , EZETAST , EZEVAST , LIPERCOSYL , LIPERTANCE , LIPTA , LIPTRUZET , MIZETAM , ORVATEZ , PARVAXOR , RESELIP , TACERNOL , TORVAZIN PLUS , TORZELIP , TRINOMIA , TRIVERAM , TULIP COMBO , ZENTASTA

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
LIPITOR Film-coated tablet
Structured Product Labeling (SPL/PLR)
US
LIPITOR Film-coated tablets
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

A0JWA85V8F - ATORVASTATIN

CAS registry number

134523-00-5 - atorvastatin

SNOMED-CT

373444002 - Atorvastatin (substance)

Next: Usage